Transaction Details

Footnotes

Transaction pursuant to Rule 10b5-1 Plan adopted on November 25, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.3000 to $45.2900. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.3500 to $46.3400. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The option becomes exercisable with respect to the remaining shares on October 9, 2026, subject to the achievement of certain stock price thresholds described in the option award.